Sentence examples for medium binding from inspiring English sources
The medium binding energy at 531.3 ± 0.1 eV corresponds to the oxygen deficiency regions, which are called oxygen vacancies [28, 29].
Furthermore, the medium binding energy component (Ob) located at 531.2 ± 0.2 eV (Oc) is associated with the O2− ions in the oxygen-deficient regions (O vacancies) [30].
Fei Xiaotong (1999) also pointed out that, as a medium binding couples biologically and psychologically, children create a common task that has to be undertaken by parents.
The medium binding energy component at the peak of 531.2 ± 0.2 eV (Ob) is attributed to lost O2- ions in oxygen deficient regions (oxygen vacancies) within the matrix of ZnO.
Kellenberger et al. [24] reported that Gold, Surflex, and FlexX perform better on small binding sites (<700 Å3), while Glide performs better on medium binding sites (700 1500 Å3), and that all programs have relatively better performance for small hydrophobic ligands.
Optimal parameters ensuring minimum irreversible capacity of the substrate were defined: medium binding of Li combined with maximum charge transfer – requirements met by BN-anthracenes and B-phenanthrenes at low degree of doping and B-anthracenes with higher B-contents, the two latter being more prospective.
Peptides and fibrinogen protein from human plasma (Calbiochem, Gibbstown, NJ, USA) were coated onto medium-binding 96-well flat-bottom polystyrene plates (Costar, Corning Inc, Corning, NY, USA) at 1 μg peptide/ml at 4°C overnight.
When cauda epididymal spermatozoa that are bound by HongrES1 were incubated in capacitation medium, the binding immunofluorescence signal attenuated gradually and disappeared (Figure 3D, 3E and 3F).
To choose an appropriate anion exchange medium, the binding capacity of two materials was determined by applying 350 units onto the column and determining breakthrough curves.
If peptides had been released into the medium before binding to the MHC molecules, cytolytic activity would not be confined to the spots bearing the CMV epitope.
The results showed that syringopicroside was a medium plasma protein binding drug and the binding rate was not dependent on the doses.
